This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Nicolas Pineau: Innovator in Pharmaceutical Compositions
Introduction
Nicolas Pineau is a notable inventor based in Carbon-Blanc, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compositions that address health-related challenges.
Latest Patents
Nicolas Pineau holds a patent for a pharmaceutical composition comprising cyclodextrin complexes of anethole trithione or derivatives thereof. This composition includes anethole trithione or a derivative thereof of formula (I), sulfobutyl ether-beta-cyclodextrin, and optionally a co-solvent. The ratio of the sulfobutyl ether-beta-cyclodextrin to the compound of formula (I) ranges from 10 to 400, preferably from 57 to 200. The composition is designed for use as a drug, specifically for the treatment and/or prevention of diseases related to free oxygen radicals. Additionally, it includes a kit-of-parts and/or a medical device that incorporates the composition, as well as a method for solubilizing the compound of formula (I) in an aqueous medium. He has 1 patent to his name.
Career Highlights
Throughout his career, Nicolas Pineau has focused on developing innovative solutions in the pharmaceutical industry. His work has contributed to advancements in drug formulations and therapeutic applications.
Collaborations
Nicolas has collaborated with notable colleagues, including El Mustapha Belgsir and Frédéric Turpin. These partnerships have enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Nicolas Pineau is a distinguished inventor whose work in pharmaceutical compositions showcases his commitment to improving health outcomes. His innovative approaches continue to influence the industry and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile